← All trials
NCT05841550
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 19, 2023
- Primary completion
- May 19, 2027
- Completion date
- May 19, 2035
- First posted
- May 3, 2023
- Last posted
- Nov 3, 2023
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OsloLead sponsor
- University of OsloReponsible party - principal investigator
- Targovax ASACollaborator
- University of OsloSponsor investigator
- University of OsloOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.